NASDAQ: TEM
Tempus AI
Health Care · Services-Computer Programming, Data Processing, Etc.
52-week range
$40.77$92.00
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$10.5B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | $5.81B |
| FY2025, ended Dec 31, 2025 | $10.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $10.5B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$1.43B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2022, ended Dec 31, 2022 | $321M |
| FY2023, ended Dec 31, 2023 | $532M |
| FY2024, ended Dec 31, 2024 | $693M |
| FY2025, ended Dec 31, 2025 | $1.27B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.43B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2022, ended Dec 31, 2022 | −$290M | −$187M |
| FY2023, ended Dec 31, 2023 | −$214M | −$249M |
| FY2024, ended Dec 31, 2024 | −$706M | −$211M |
| FY2025, ended Dec 31, 2025 | −$245M | −$239M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | −$254M | −$263M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$600M
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2022, ended Dec 31, 2022 | $303M |
| FY2023, ended Dec 31, 2023 | $166M |
| FY2024, ended Dec 31, 2024 | $341M |
| FY2025, ended Dec 31, 2025 | $605M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $600M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$188M
Show tableHide table
| Period | Total debt |
|---|---|
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | $193M |
| FY2024, ended Dec 31, 2024 | $168M |
| FY2025, ended Dec 31, 2025 | $209M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $188M |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 286,159% since 2022.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.180M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2022, ended Dec 31, 2022 | 63.0K |
| FY2023, ended Dec 31, 2023 | 63.3K |
| FY2024, ended Dec 31, 2024 | 172M |
| FY2025, ended Dec 31, 2025 | 179M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 180M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Net: $186M more issued than bought back
Show tableHide table
| Period | Paid to employees | Used in acquisitions |
|---|---|---|
| FY2022, ended Dec 31, 2022 | $0 | — |
| FY2023, ended Dec 31, 2023 | $0 | $9.21M |
| FY2024, ended Dec 31, 2024 | $534M | $344K |
| FY2025, ended Dec 31, 2025 | $125M | $403M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $186M | — |
Revenue (TTM)
$1.43B
+50.4% YoY
Net income (TTM)
−$254M
n/m YoY
Cash
$600M
+222% YoY
Total debt
$188M
−17.0% YoY
Valuation
At current price- Market Cap
- $13.8B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 9.7×
- Price / Book
- 31.1×
- EV / EBITDA
- n/m. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $1.43B
- Revenue Growth YoY
- 50.4%
- Revenue CAGR 3Y
- 58.3%
- Revenue CAGR 5Y
- —. Compound annual growth over the last 5 fiscal years
- EPS Growth YoY
- −167%
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- −19.8%
- Net Margin
- −17.8%
- FCF Margin
- −18.4%
- Return on Equity
- −67.4%
Earnings
Trailing 12 months- Net Income
- −$254M
- EPS (diluted)
- −$1.44
- EBITDA
- −$253M
- Operating Income
- −$283M
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $600M
- Total Debt
- $188M
- Net Cash
- $412M
- Total Assets
- $2.37B
- Total Liabilities
- $1.92B
- Shareholders' Equity
- $445M
Cash Flow
Trailing 12 months- Operating Cash Flow
- −$237M
- Capital Expenditure
- $25.8M
- Free Cash Flow
- −$263M
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 3.51
Every ratio is calculated from the company’s reported figures.
Strength
Revenue grew 50.4% over the last year, to $1.43B.
Watch
Lost $254M over the last 12 months.
Strength
Holds more cash than debt, with $412M in net cash.
Watch
Free cash flow was negative (−$263M) over the last year.
Written by fixed rules from the reported figures, not by a person or an AI.
From the 10-Q for Q2 FY2026 (period ended Jun 30, 2026), filed Jul 30, 2026. View filings on SEC EDGAR